In the Southeast United States, increasingly frequent and severe hurricanes and floods are exposing weak links in the country's medical supply chains. Warmer oceans are supercharging these storms—and as climate change continues, it is placing strain on a system built on single-site manufacturing, just-in-time inventory, and fragile last-mile connections. The U.S. medical supply chain still struggles to find the balance between cost efficiency and resiliency—while paying attention to durability—according to Chris Luoma, Senior VP of Strategy at healthcare supply chain software provider Global Healthcare Exchange (GHX). When Hurricane Helene made landfall in late September 2024, it devastated large swaths of Florida and Georgia. But less dramatic yet intense precipitation and flooding in North Carolina had ripple effects lasting months—because medical device manufacturer Baxter International was forced to shut down its North Cove facility in the state, a plant that produces a significant portion of intravenous (IV) fluids.
From a supply chain perspective, Baxter International Inc., based in Deerfield, Illinois, is a Fortune 500 medical device and healthcare services company, with Joe Almeida serving as Chairman & CEO. The Baxter North Cove Plant in Marion, North Carolina, produces approximately 60% of all IV fluids in the U.S.—making it a critical single-site chokepoint for the nation. Hurricane Helene (September 26–29, 2024) made landfall as a Category 4 hurricane at Big Bend, Florida—cutting across North Carolina, South Carolina, Georgia, Tennessee, and Virginia—resulting in 230+ deaths and over $250 billion in economic losses. Asheville, North Carolina; Boone; Black Mountain; and Swannanoa were among the hardest-hit areas. Global Healthcare Exchange (GHX), based in Louisville, Colorado, is a healthcare supply chain automation platform, with Tina Vatanka Murphy serving as President & CEO. HealthTrust Purchasing Group, Premier Inc., and Vizient are major U.S. healthcare GPOs (Group Purchasing Organizations).
From a supply chain perspective, the U.S. medical supply chain includes major pharmaceutical and medical device distributors such as Cardinal Health (Dublin, Ohio); McKesson Corporation (Irving, Texas); AmerisourceBergen/Cencora (Conshohocken, Pennsylvania); Owens & Minor (Mechanicsville, Virginia); Henry Schein (Melville, New York); and Medline Industries (Northfield, Illinois). Major U.S. pharmaceutical companies include Johnson & Johnson; Pfizer; Merck; AbbVie; Eli Lilly; Bristol Myers Squibb; Amgen; Gilead Sciences; Moderna; Regeneron; and Vertex. Major U.S. medical device companies include Medtronic (Galway, Ireland); Stryker; Boston Scientific; Becton Dickinson; Abbott Laboratories; Edwards Lifesciences; Intuitive Surgical; Zimmer Biomet; Hologic; Dexcom; Insulet; and Tandem Diabetes. Key U.S. healthcare supply chain regulators and strategic agencies include the FDA (Food and Drug Administration); CMS (Centers for Medicare & Medicaid Services); HHS ASPR (Administration for Strategic Preparedness and Response); BARDA (Biomedical Advanced Research and Development Authority); and the Strategic National Stockpile (SNS).
From a supply chain perspective, climate change's impacts on medical supply chains include: (1) hurricanes and floods causing damage to manufacturing facilities, warehouses, distribution centers, and transportation infrastructure; (2) extreme heat threatening the stability of temperature-sensitive pharmaceuticals and vaccines, increasing data center cooling demands, and affecting worker health; (3) wildfires in California, the Pacific Northwest, and Canada disrupting supply flows; (4) drought straining clean water availability for manufacturing and agricultural sources of pharmaceutical ingredients; (5) sea level rise threatening port infrastructure and coastal facilities; and (6) extreme weather prediction challenges complicating inventory planning and logistics route optimization. Resilient supply chain strategies include: (1) geographic diversification through multi-site manufacturing; (2) increasing safety stock by recalibrating safety stock levels; (3) nearshoring and reshoring; (4) supplier visibility platforms offering n-tier visibility; (5) scenario planning and stress testing; and (6) climate risk modeling and insurance. Major supply chain risk intelligence platforms include Resilinc; Everstream Analytics; Interos; riskmethods (Sphera); Prewave; and Craft.co. Ultimately, the Baxter North Cove experience represents a critical wake-up call for the U.S. medical supply chain to place climate resiliency alongside the balance between cost efficiency and durability.
Key Takeaways:
1. Hurricane Helene in September 2024 caused the closure of the Baxter North Cove facility.
2. Baxter North Cove is a critical single-site chokepoint, producing 60% of U.S. IV fluids.
3. Chris Luoma at GHX emphasizes the importance of balancing cost efficiency, durability, and resiliency.
4. Single-site manufacturing, JIT inventory, and fragile last-mile connections are among the key weak links.
5. Geographic diversification, safety stock increases, nearshoring, supplier visibility, and climate risk modeling are core resilience strategies.
